Boehringer Ingelheim

For Healthcare Professionals

Logout

Boehringer Ingelheim

Boehringer Ingelheim

Boehringer Ingelheim

Therapeutic Area
Therapeutic Area

At Boehringer Ingelheim we are driven by the desire to serve mankind by improving human and animal health. As a successful, family owned company we plan in generations. We work together globally and with integrity. Our Focus articulates who we are and what we strive for, how we work and what we want to achieve.

Section Overview

Therapeutic Area

Section Overview

Cardiovascular

Metabolic

Inflammation

Respiratory
Products
Products

Boehringer Ingelheim is a research-driven group of companies dedicated to the discovery, development, manufacture and marketing of innovative health care products.

See all products

Products

See all products
Resources
Contact
Logout

Boehringer Ingelheim

VIDEOS

Prof. Wanner - Why early kidney screening by PCP

00:01:02

Prof. Wanner - Why early kidney screening by PCP

Watch now Opens in new tab

Prof. Green - Latest guideline in patients with T2D, CKD

1:15

Prof. Green - Latest guideline in patients with T2D, CKD

Watch now Opens in new tab

Dr. Brendon - 26.6 delay to kidney replacement therapy

0:45

Dr. Brendon - 26.6 delay to kidney replacement therapy

Watch now Opens in new tab

SIP||HCP's role in CKD management, when to refer

0:57

SIP||What is the role of primary care in CKD management?

Watch now Opens in new tab

SIP||PCP’s role in DKD management & when to refer to endocrinologist

1:52

SIP||Why should medications with organ protection be initiated early for people with diabetes?

Watch now Opens in new tab

SIP||What does kidney function preservation in EMPA-KIDNEY mean to you?

1:05

SIP||How consistent is the renal protective benefits of Empagliflozin based on evidence?

Watch now Opens in new tab

Pagination

Load More

Sitemap

Therapeutic Area

Resources
- Videos
- Clinical studies

BI logo

Privacy
Terms of use
Sitemap
Contact

Copyright © 2025 Boehringer Ingelheim (Philippines), Inc. All rights reserved. Use of this Site is subject to the Terms of Use and Privacy Statement. Prepared June 2025